Cross-Site Scripting Vulnerability in IBM OPENBMC OP910
CVE-2021-38961

6.1MEDIUM

Key Information:

Vendor

IBM
Status
Openbmc
Vendor
CVE Published:
27 December 2021

What is CVE-2021-38961?

IBM OPENBMC OP910 is susceptible to cross-site scripting, enabling attackers to inject malicious JavaScript into the web interface. This flaw may allow unauthorized manipulation of functionality, jeopardizing sensitive user credentials within a trusted session. To mitigate risks, it is crucial for users to remain vigilant about potential exploitation and apply necessary patches as soon as they are available.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

OPENBMC OP910

References

https://www.ibm.com/support/pages/node/6536720
x_refsource_CONFIRM
https://exchange.xforce.ibmcloud.com/vulnerabilities/212049
vdb-entryx_refsource_XF

CVSS V3.1

Score:
6.1
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.